Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer

NCT07562711 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

340

Enrollment

OTHER

Sponsor class

Conditions

ctDNA
Chemotherapy
Colorectal Cancer

Interventions

DRUG: Capecitabine
DRUG: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)

Sponsor

Fudan University